Teva/VCCP on top at PM Society ad awards
pharmafile | February 3, 2014 | News story | Medical Communications, Sales and Marketing | 2014, Teva, ads, advertising, neil smith, pm awards, vccp
Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured competition from 37 pharma companies and 27 agencies.
A broad spread of successful agencies this year saw VCCP walk away with three wins (for Copaxone), while Langland – who have been the outright winners many times in the past – celebrated two wins alongside Saatchi & Saatchi Health and woolley pau gyro.
On the client side, Israeli generics firm Teva had 11 nominations with two agencies and received four wins (Teva Respiratory by woolley pau gyro and with its multiple sclerosis drug Copaxone by VCCP Health), as well as two highly commended and three commended.
Japanese pharma firm Takeda had the most nominations at 14, but walked away with just one win (Calcichew D3 Forte/Caplet by Swordfish Advertising). It also had three highly commended and four commended awards from three different agencies.
Fellow Japanese firm Astellas had eight nominations working with three different agencies and took home two highly commended, and one commended.
There were seven nominations for Sanofi Pasteur MSD – resulting in one win (Let’s Talk Flu Nurse by Bedgebury Communications) and three commended awards. The Geoff Brook Innovation Award went to Frontera London for the campaign Lung Clock for Quit.
OPEN LEC won the Service Industry Award for its LUTS Video with a highly commended for Orphan Europe (The Personal Touch) for nitrogen, and a commendation going to Open the HUG Box for HUG Advertising and Seed Bomb for Cherry.
There were only three individual campaigns securing more than three nominations: Xtandi for Astellas by VCCP had six nominations and took home a commended.
Let’s Talk Flu for Sanofi Pasteur MSD by Bedgebury secured five nominations of which there was one commended and a winner, and Calcichew D3 Forte/Caplet for Takeda by Swordfish was nominated four times, going on to receive four commended and one winning awards.
Neil Smith, the PM Society Advertising Awards chairman, said: “More than just a ceremony, the PM Society Advertising Awards remains the only opportunity, annually, to see the best of the best in this key aspect of marketing communications, with the entrants’ exhibition and categories judged by peers, industry and healthcare professionals.
“Entries into the Patient Information Campaign category were particularly high this year, maybe suggesting an industry trend towards improving patient communications, ultimately to drive better patient outcomes.”
Ben Adams
Related Content
Sanofi and Teva partner for development of inflammatory bowel disease treatment
Sanofi and Teva Pharmaceuticals have announced that they will collaborate for the co-development and co-commercialisation …
Teva’s cancer drug Bendeka protected from generics until 2031, judge rules
A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe …
Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine
NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of …
